# Petmed Express Inc: Form 10-Q for the period ended Sep 30, 2020

- Company: [Petmed Express Inc](/companies/pets.md) (CIK 1040130)
- Form: 10-Q
- Filed: 2020-11-03
- Accepted by EDGAR: Nov 3, 2020, 15:22 ET
- Period: 2020-09-30
- Accession: 0001437749-20-022358
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1040130/000143774920022358/pets20200930_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1040130/000143774920022358/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-07-01 to 2020-09-30 | $75.4m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months, 2020-04-01 to 2020-09-30 | $171.6m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months, 2020-07-01 to 2020-09-30 | $52.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2020-04-01 to 2020-09-30 | $121.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-07-01 to 2020-09-30 | $23.0m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2020-04-01 to 2020-09-30 | $49.8m | us-gaap:GrossProfit |
| Operating income | 3 months, 2020-07-01 to 2020-09-30 | $10.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2020-04-01 to 2020-09-30 | $19.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2020-07-01 to 2020-09-30 | $2.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2020-04-01 to 2020-09-30 | $4.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-07-01 to 2020-09-30 | $8.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2020-04-01 to 2020-09-30 | $16.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-07-01 to 2020-09-30 | $0.42 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2020-04-01 to 2020-09-30 | $0.81 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-07-01 to 2020-09-30 | $0.42 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2020-04-01 to 2020-09-30 | $0.81 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-07-01 to 2020-09-30 | 20,154,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2020-04-01 to 2020-09-30 | 20,098,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2020-04-01 to 2020-09-30 | $15.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2020-04-01 to 2020-09-30 | $1.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2020-04-01 to 2020-09-30 | $11.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2020-04-01 to 2020-09-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-09-30 | $106.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-09-30 | $132.6m | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-30 | $158.9m | us-gaap:Assets |
| Current liabilities | at 2020-09-30 | $21.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-09-30 | $22.5m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-09-30 | $136.4m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1040130/000143774920022358/pets20200930_10q.htm

Filed Nov 3, 2020.
Source: SEC EDGAR, the filing index for accession 0001437749-20-022358. Last ingested by Listed: Nov 13, 2026, 14:26 ET. No prices; not investment advice.
